Skip to content
stoqly

Herbalife Ltd.

HLF NYSE Wholesale-Drugs, Proprietaries & Druggists' Sundries Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$5.0B
0.9% vs prior year
Operating margin Operating income as a share of revenue.
9.5%
1.8 pts
Net income Profit after all expenses, interest and tax.
$228M
10.2%
Free cash flow Cash from operations minus capital spending.
$253M
54.8%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
35.4%
1.6 pts
Market cap Last close times the latest diluted share count, so it is approximate.
—
P/E Last close divided by diluted earnings per share over the last four quarters.
—
On $1.55 EPS (TTM)

What Herbalife Ltd. does

No business description yet.

Legal name
HERBALIFE LTD.
Fiscal year ends
December 31, 2025
Latest annual report
10-K · Feb 18, 2026
Accession · CIK
0001193125-26-057113
0001180262

Revenue and margins

Herbalife Ltd. had $5.0B of revenue in fiscal 2025, up 0.9% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 4.3% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $253M in fiscal 2025, 5.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Herbalife Ltd. returned $8.2M to shareholders in fiscal 2025, 3% of free cash flow. The diluted share count rose 2.0%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Herbalife Ltd. can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $602M$508M$575M$415M$353M
Debt incl. finance leases $2.8B$2.7B$2.6B$2.3B$2.0B
Net debt / EBITDA 2.6x3.3x4.2x3.6x2.7x
Interest coverage 4.8x3.9x2.1x1.8x2.2x
Current ratio 1.3x1.4x1.1x0.9x1.1x
Quick ratio 0.8x0.8x0.7x0.5x0.6x
Total assets $2.8B$2.7B$2.8B$2.7B$2.8B
Total liabilities $4.2B$4.0B$3.9B$3.5B$3.3B
Shareholders' equity −$1.4B−$1.3B−$1.1B−$801M−$515M
Net debt (− = net cash) $2.2B$2.2B$2.0B$1.8B$1.6B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Return on assets rose — ✕ ✓ ✓ ✓ ✓ ✕ ✕ ✓ ✕
Cash from operations exceeds net income ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Debt fell relative to assets — ✕ ✕ ✓ ✕ ✕ ✕ ✓ ✓ ✓
Current ratio rose — ✓ ✕ ✓ ✓ ✕ ✓ ✕ ✕ ✓
Share count didn't rise — ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✕ ✕
Gross margin rose — ✕ ✓ ✕ ✕ ✕ ✕ ✕ ✓ ✕
Revenue rose relative to assets — ✕ ✓ ✓ ✕ ✓ ✕ ✕ ✓ ✕
F-score — / 35 / 97 / 98 / 96 / 96 / 95 / 94 / 97 / 95 / 9
Accruals ratio −4.2%−13.8%−12.4%−5.4%−8.9%−0.4%−1.1%−7.8%−1.1%−3.8%
Altman Z'' 2.923.201.322.311.830.870.48−0.38−0.460.63

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $4.5B $4.4B $4.9B $4.9B $5.5B $5.8B $5.2B $5.1B $5.0B $5.0B
Gross profit $3.6B $3.6B $4.0B $3.9B $4.4B $4.6B $4.0B $3.9B $3.9B $3.9B
Operating income $458M $617M $683M $568M $641M $734M $545M $356M $386M $481M
Interest expense $99.3M $161M $181M $153M $133M $153M $139M $166M $218M $214M
Pretax income $365M $471M $464M $451M $516M $561M $425M $203M $169M $275M
Income tax $105M $257M $168M $140M $144M $114M $104M $60.8M −$84.9M $47.3M
Net income $260M $214M $297M $311M $373M $447M $321M $142M $254M $228M
Diluted EPS $1.51 $1.29 $1.98 $2.20 $2.77 $4.13 $3.23 $1.42 $2.50 $2.20
Diluted shares 0.17B 0.17B 0.15B 0.14B 0.13B 0.11B 0.10B 0.10B 0.10B 0.10B
Cash flow
Cash from operations $367M $591M $648M $458M $629M $460M $353M $358M $285M $333M
Capital expenditure $143M $95.5M $84.0M $106M $112M $151M $156M $135M $122M $80.4M
Free cash flow $224M $495M $564M $351M $517M $309M $196M $223M $163M $253M
Depreciation and amortization $98.3M $99.8M $100M $97.7M $100M $108M $115M $113M $121M $121M
Stock-based compensation $40.2M $42.1M $35.5M $38.6M $51.0M $54.1M $44.4M $48.0M $50.0M $44.1M
Acquisitions — — — — — — — $0.0M $0.0M $25.5M
Share buybacks $13.2M $844M $750M $16.7M $924M $1.0B $147M $11.0M $8.3M $8.2M
Dividends paid $0.0M $0.0M $0.0M — — — — — — —
Dividends and buybacks $13.2M $844M $750M $16.7M $924M $1.0B $147M $11.0M $8.3M $8.2M
Balance sheet
Cash and short-term investments $844M $1.3B $1.2B $839M $1.0B $602M $508M $575M $415M $353M
Total debt $1.4B $2.3B $2.5B $1.8B $2.4B $2.8B $2.7B $2.6B $2.3B $2.0B
Finance lease liabilities — — — $1.1M $0.5M $1.1M $1.3M $1.7M $2.0M $2.5M
Current assets $1.5B $1.9B $1.8B $1.5B $1.8B $1.4B $1.4B $1.4B $1.1B $1.1B
Current liabilities $792M $907M $1.6B $964M $1.1B $1.1B $977M $1.3B $1.2B $1.0B
Inventory $371M $341M $382M $436M $501M $576M $581M $505M $475M $512M
Property and equipment, net $378M $378M $360M $372M $390M $442M $486M $507M $460M $448M
Goodwill $89.9M $96.9M $92.9M $91.5M $101M $95.4M $93.2M $95.4M $87.7M $101M
Intangible assets $310M $310M $310M $310M $313M $317M $316M $314M $312M $315M
Total assets $2.6B $2.9B $2.8B $2.7B $3.1B $2.8B $2.7B $2.8B $2.7B $2.8B
Total liabilities $2.4B $3.2B $3.5B $3.1B $3.9B $4.2B $4.0B $3.9B $3.5B $3.3B
Shareholders' equity $196M −$335M −$723M −$390M −$856M −$1.4B −$1.3B −$1.1B −$801M −$515M
Margins
Gross margin 81.0% 80.8% 81.2% 80.4% 79.2% 78.6% 77.4% 76.5% 77.9% 77.9%
Operating margin 10.2% 13.9% 14.0% 11.6% 11.6% 12.7% 10.5% 7.0% 7.7% 9.5%
EBITDA margin 12.4% 16.2% 16.0% 13.7% 13.4% 14.5% 12.7% 9.3% 10.2% 12.0%
Net margin 5.8% 4.8% 6.1% 6.4% 6.7% 7.7% 6.2% 2.8% 5.1% 4.5%
FCF margin 5.0% 11.2% 11.5% 7.2% 9.3% 5.3% 3.8% 4.4% 3.3% 5.0%
Returns
Return on capital 40.8% 61.3% 83.5% 68.2% 87.7% 76.1% 44.9% 26.9% 37.0% 35.4%
Return on capital employed 25.8% 31.0% 56.9% 33.1% 32.9% 42.2% 31.1% 23.3% 25.8% 27.1%
Return on equity 132.5% — — — — — — — — —
Return on assets 10.1% 7.8% 10.4% 11.4% 12.9% 15.2% 11.6% 5.1% 9.2% 8.3%
Growth
Revenue growth — −1.4% 10.5% −0.3% 13.6% 4.7% −10.3% −2.7% −1.4% 0.9%
Net income growth — −17.7% 38.7% 4.9% 19.8% 20.0% −28.2% −55.7% 78.8% −10.2%
EPS growth — −14.6% 53.5% 11.1% 25.9% 49.1% −21.8% −56.0% 76.1% −12.0%
FCF growth — 121.2% 14.0% −37.7% 47.0% −40.2% −36.5% 13.5% −26.6% 54.8%
Share count change — −3.8% −9.8% −5.3% −5.0% −19.5% −8.1% 0.7% 1.4% 2.0%
Financial health
Net debt / EBITDA 1.1x 1.4x 1.6x 1.4x 1.9x 2.6x 3.3x 4.2x 3.6x 2.7x
Debt / equity 7.4x — — — — — — — — —
Interest coverage 4.6x 3.8x 3.8x 3.7x 4.8x 4.8x 3.9x 2.1x 1.8x 2.2x
Current ratio 1.8x 2.1x 1.1x 1.5x 1.6x 1.3x 1.4x 1.1x 0.9x 1.1x
Quick ratio 1.4x 1.7x 0.9x 1.1x 1.1x 0.8x 0.8x 0.7x 0.5x 0.6x
Capital allocation
Capex / revenue 3.2% 2.2% 1.7% 2.2% 2.0% 2.6% 3.0% 2.7% 2.4% 1.6%
Stock comp / revenue 0.9% 1.0% 0.7% 0.8% 0.9% 0.9% 0.9% 0.9% 1.0% 0.9%
Payouts / FCF 5.9% 170.4% 132.9% 4.8% 178.8% 327.4% 74.8% 4.9% 5.1% 3.2%
Quality scores
Piotroski F-score — 5.0 7.0 8.0 6.0 6.0 5.0 4.0 7.0 5.0
Altman Z'' 2.9 3.2 1.3 2.3 1.8 0.9 0.5 −0.4 −0.5 0.6
Accruals ratio −4.2% −13.8% −12.4% −5.4% −8.9% −0.4% −1.1% −7.8% −1.1% −3.8%

Source: SEC EDGAR XBRL filings (CIK 0001180262). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open